Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome

Acta Odontologica Scandinavica

Volumn 61, Issue 3, 2003, Pages 154-158

  Tsilingaridis, Georgios ^a   Yucel Lindberg, Tülay ^a   Modéer, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cervicular fluid; Down syndrome; Periodontal disease; PGE2; PGE2MMP 9

Indexed keywords

GELATINASE B; LEUKOTRIENE B4; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; GINGIVITIS; HUMAN; IMMUNE RESPONSE; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SCHOOL CHILD; TOOTH;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; DINOPROSTONE; DOWN SYNDROME; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVAL POCKET; GINGIVITIS; HUMANS; LEUKOTRIENE B4; LINEAR MODELS; MATRIX METALLOPROTEINASE 9; PERIODONTAL INDEX;

EID: 0038787495     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016350310002270     Document Type: Article

References (32)

1. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatique de neuf enfante mongolien. C R Acad Sci 1959;248:1721-22.
2. Ulseth JD, Hestnes A, Stavner LJ, Storhaug K. Dental caries and periodontitis in persons with Down's syndrome. Spec Care Dent 199;11:71-3.
3. Pueschel SM, Annerén G, Durlach R, Flores J, Sustrova M, Verma IC. Medical care in Down syndrome. Acta Paediatr Scand 1995;84:823-7.
4. Barkin RM, Weston WL, Humbert JR, Maine F. Phagocytic function in Down's syndrome. I. Chemotaxis. J Ment Defic Res 1980;24:243-9.
5. Annerén G, Björksten B. Low superoxide levels in blood phagocytic cells in Down's syndrome. Acta Paediatr Scand 1984;73:345-8.
6. Levin S. The immune system and susceptibility to infections in Down's syndrome. Prog Clin Biol Res 1987;246:143-62.
7. 4 by selenium supplementation in children with Down's syndrome. Arch Dis Child 1990;65:1353-5.
8. Barnett ML, Press KP, Friedman D, Sonnenberg EM. The prevalence of periodontitis and dental caries in a Down's syndrome population. J Periodontol 1986;57:288-93.
9. Reuland Bosma W, van Dijk LJ. Periodontal disease in Down's syndrome: A review. J Clin Periodontol 1986;13:64-73.
10. Modéer T, Barr M, Dahllöf G. Periodontal disease in children with Down's syndrome. Scand J Dent Res 1990;98:228-34.
11. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-10.
12. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 199;26:230-42.
13. 2 and tumor necrosis factor alpha in experimental gingivitis in human. J Periodont Res 1993;28:241-7.
14. 2 level in gingival crevicular fluid from patients with Down's syndrome. Acta Odontol Scand 1997;55:101-5.
15. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-12.
16. Offenbacher S, Odle BM, Braswell LD, Johnson HG, Hall CM, McClure H, et al. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodont Res 1989;24:63-74.
17. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.
18. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70-6.
19. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Oral Dis 1998;4:231-40.
20. Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YJ, et al. Characterization of matrix metalloproteinase (MMP-8 and -9). Activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 1996;67:748-54.
21. Axelsson P, Lindhe, J. Effect of fluoride on gingivitis and dental caries in preventive program based on plaque control. Community Dent Oral Epidemiol 1975;3:56-60.
22. Källestål C, Matsson L. Criteria for assessment of interproximal bone loss on bitewing radiographs in adolescents. J Clin Periodontol 1989;16:300-4.
23. Granström E. The arachidonic acid cascade. The prostaglandins, thromboxanes and leukotrienes. Inflammation 1984;8:15-25.
24. Barr-Agholme M, Dahllöf G, Linder L, Modéer T. Actinobacillus actinomycetemcomitans, Capnocytophaga and Phorphyromonas gingivalis in subgingival plaque of adolescents with Down's syndome. Oral Microbiol Immunol 1992;7:244-48.
25. 2 but not IL-beta in patients with adult periodontitis. J Periodontal Res 1989;24:88-95.
26. McLaren J, Taylor DJ, Bell SC. Prostaglandin E (2)-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes. Mol Hum Reprod 2000;6:1033-40.
27. Wahl LM, Corcoran ML. Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol 1993;64:467-73.
28. Soell M, Elkaim R, Tenenbaum H. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 2002;81:174-8.
29. Yavuzyilmaz E, Ersoy F, Sanal O, Tezcan I, Ercal D. Neutrophil chemotaxis and periodontal status in Down's syndrome patients. J Nihon Univ Sch Dent 1993;35:91-5.
30. Makela M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994;73:1397-406.
31. Smolian H, Aurer A, Sittinger M, Zacher J, Bernimoulin JP, Burmester GR, et al.Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts. Biol Chem 2001;382:1491-9.
32. Lechapt-Zalcman E, Escudier E. Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases. Morphologie 2000;84:45-9.